An Engineered Design of Self-Assembly Nanomedicine Guided by Molecular Dynamic Simulation for Photodynamic and Hypoxia-Directed Therapy
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Yu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Zhejiang University, Hangzhou 310058, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
ORCID-Profile: Guping Tang, Hongzhen Bai
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Y., Zhang, H., Wang, J., Tang, G., & Bai, H. (2023). An Engineered Design of Self-Assembly Nanomedicine Guided by Molecular Dynamic Simulation for Photodynamic and Hypoxia-Directed Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01079
Vancouver
Wang Y, Zhang H, Wang J, Tang G, Bai H. An Engineered Design of Self-Assembly Nanomedicine Guided by Molecular Dynamic Simulation for Photodynamic and Hypoxia-Directed Therapy. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01079
BibTeX
@article{Wang2023,
author = {Wang, Yu and Zhang, Haotian and Wang, Jianwei and Tang, Guping and Bai, Hongzhen},
title = {An Engineered Design of Self-Assembly Nanomedicine Guided by Molecular Dynamic Simulation for Photodynamic and Hypoxia-Directed Therapy},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01079}
}
EUVIMED